longbridge

Dizal Pharmaceutical

688192
----

All Shareholders

Shareholder Type

  • Public companies23.42%
  • VC/PE firms23.42%
  • Institutions18.17%
  • Public and others18.08%
  • Others16.93%

Major Shareholders

Major Shareholders Latest
Shareholder
AstraZeneca PLC
23.42%108.92M0.03%+0
SDIC Innovation Investment Management Co., Ltd.
23.42%108.92M0.03%+0
Jiangsu Wuxi Dizhe Enterprise Management Partnership Enterprise (Limited Partnership)
12.35%57.45M0.00%+0
Zhang XiaolinGM & Chairman
1.94%9.03M0.00%+0
Rosefinch Fund Management Co., Ltd.
1.84%8.54M<0.01%+0
Wuxi Xintou Jinshi Venture Capital Management Co., Ltd.
1.63%7.60M<0.01%+0
Maxwealth Fund Management Co., Ltd
1.30%6.07M<0.01%+0
Harvest Fund Management Co. Ltd.
1.16%5.40M<0.01%+0
Dezent Partners Limited
1.11%5.17M0.00%+0
Penghua Fund Management Co., Ltd.
1.08%5.03M<0.01%+0
China Southern Asset Management Co., Ltd.
0.95%4.41M<0.01%+0
Shanghai Orient Securities Asset Management Co., Ltd.
0.93%4.31M<0.01%+0
Zhenfan YangDeputy GM & Chief Medical Officer
0.75%3.51M0.04%-194.16K
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
0.67%3.11M<0.01%+0
Zhong Ou Fund Management Co., Ltd
0.66%3.05M<0.01%+0
JP Morgan Asset Management
0.63%2.95M0.00%+0
Ping An UOB Fund Management Co., Ltd.
0.55%2.58M<0.01%+0
Shanghai Liyi Investment Management Partnership (Limited Partnership)
0.53%2.48M<0.01%+0
Bosera Asset Management Co., Ltd.
0.48%2.26M<0.01%+0
China Merchants Fund Management Company Ltd.
0.47%2.20M<0.01%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy